spacer
home > ict > autumn 2019 > software solutions
PUBLICATIONS
International Clinical Trials

Software Solutions






ICT: What are some of the marketplace trends for clinical trial management systems (CTMS)?

Ricky Lakhani: Historically, CTMS solutions have been rightly considered expensive, monolithic, and costly to both implement and maintain. Through improvements in technology, this has begun to change with Software-as-a- Service (SaaS) offerings. The continued growth and adoption of SaaS technology solutions, especially with a CTMS, will be a key industry trend in the coming years. This is true for smalland medium-sized companies striving to reduce the cost/ overhead of either home-grown or hosted solutions. Further to that, with the continued focus on data collection and analysis, companies are adopting CTMS solutions to eradicate the inefficiencies of spreadsheets and other manual tools. In regard to data collection, CTMS solutions are increasingly positioning themselves in the middle of an ecosystem of inbound and outbound data, reducing the amount of manual data entry and increasing the transparency of data for reporting and informed decision making.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Ricky Lakhani is a product management professional with more than a decade of global experience specialising in understanding customer requirements and developing products that are valuable, innovative, and successful in supporting pharmacovigilance and clinical operations for life science organisations. Ricky is responsible for managing the entire product lifecycle from product strategy, planning, and definition to development and delivery.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline

Sanofi announced today an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional research milestone-based payments.
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement